CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Chief Operating Officer acquired 72,993 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 58,394 shares (grant or award)
- 4 Grant or award Chief of R&D acquired 87,591 shares (grant or award)
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market buy Director bought 20,000 shares at $1.30 ($26,000)
- 4 Open-market buy Director bought 10,000 shares at $1.23 ($12,300)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 5,000 shares at $1.49 ($7,450)
- 4 Open-market buy Director bought 7,500 shares at $1.48 ($11,100)
- 4 Open-market buy Director bought 20,000 shares at $1.49 ($29,800)
- 4 Open-market buy Director bought 10,000 shares at $1.20 ($12,000)
- 4 Open-market buy Director bought 18,000 shares at $1.24 ($22,320)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
Page 3 of 21 · 420 filings